secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001104659-21-133657
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics appoints Ellen Richstone to board; director Breedlove resigns
--------------------------------------------------------------------------------

- Board increased from six to seven directors; Ellen B. Richstone appointed as Class I director effective Nov 1, 2021.
- Richstone will chair the Audit Committee and qualifies as audit committee financial expert under SEC rules.
- Received option to purchase 16,670 shares at $12.10 per share, vesting monthly over 36 months.
- Director Mark H. Breedlove notified resignation effective Dec 31, 2021; decision not due to any disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465921133657/0001104659-21-133657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465921133657/tm2131759d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-133657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer